“…A total of 10 published articles regarding the relationship between GSTs and ovarian cancer were identified by applying the inclusion criteria (Figure 1) (Sarhanis et al, 1996;Hengstler et al, 1998;Lallas et al, 2000;Baxter et al, 2001;Spurdle et al, 2001;Morari et al, 2006;Delort et al, 2008;Gates et al, 2008;Khokhrin et al, 2012;Oliveira et al, 2012), 10 articles documented GSTM1 (2578 cases and 3423 controls) (Sarhanis et al, DOI:http://dx.doi.org/10.7314/APJCP.2014.15.15.6131 GST Genetic Polymorphisms andSusceptibility to Ovarian Cancer 1996;Hengstler et al, 1998;Whalen et al, 1998;Lallas et al, 2000;Baxter et al, 2001;Clayton et al, 2001;Riman et al, 2002;Gates et al, 2008;Oliveira et al, 2012), 8 articles studied GSTT1 (2133 cases and 3141 controls) (Sarhanis et al, 1996;Hengstler et al, 1998;Spurdle et al, 2001;Morari et al, 2006;Gates et al, 2008;Khokhrin et al, 2012;Oliveira et al, 2012) and 5 articles reported GSTP1 rs1695 (641 cases and 1949 controls) (Spurdle et al, 2001;Morari et al, 2006;Delort et al, 2008;Khokhrin et al, 2012;Oliveira et al, 2012). More details of these studies were summarized in (Supplementary Table 1).…”